tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
ARQT
Arcutis Biotherapeutics
RESEARCH TOOLSreports
Want to see ARQT full AI Analyst Report?

Arcutis Biotherapeutics (ARQT) Income Statement

966 Followers

Arcutis Biotherapeutics Income Statement

Last quarter (Q4 2025), Arcutis Biotherapeutics's total revenue was $129.50M, an increase of 81.48% from the same quarter last year. In Q4, Arcutis Biotherapeutics's net income was $17.39M. See Arcutis Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 376.07M$ 196.54M$ 59.61M$ 3.69M$ 0.00
Gross Profit
$ 339.38M$ 177.41M$ 54.62M$ 2.93M$ -763.00K
Operating Expenses
$ 351.60M$ 305.81M$ 295.72M$ 304.56M$ 205.77M
Depreciation and Amortization
$ 5.37M$ 2.60M$ 1.88M$ 1.25M$ 763.00K
EBITDA
$ 2.48M$ -109.63M$ -227.43M$ -294.55M$ -205.59M
Operating Income
$ -12.23M$ -128.40M$ -241.10M$ -301.63M$ -206.53M
Other Income/Expenses
$ -2.74M$ -10.99M$ -17.93M$ -9.83M$ 173.00K
Pretax Income
$ -14.97M$ -139.39M$ -259.03M$ -311.46M$ -206.36M
Net Income
$ -16.14M$ -140.04M$ -262.14M$ -311.46M$ -206.36M
Per Share Metrics
Basic EPS
$ -0.13$ -1.16$ -3.78$ -5.66$ -4.17
Diluted EPS
$ -0.13$ -1.16$ -3.78$ -5.66$ -4.17
Weighted Average Shares Outstanding
 127.23M 120.96M 69.31M 55.03M 49.41M
Weighted Average Shares Outstanding (Diluted)
 127.23M 120.96M 69.31M 55.03M 49.41M
Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History